Michael J. Brennan
Director/Board Member at Cloud Pharmaceuticals, Inc.
Profile
Dr. Michael J.
Brennan is a Managing Director at Pearl Street Venture Funds.
Prior to Pearl Street,he was a General Partner at Oxford Bioscience Partners.
Prior to that, he was President and Chief Executive Officer of Gene Logic.
During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion.
He raised three rounds of venture capital and led Gene Logic to an IPO in November, 1997 and a large secondary public offering in January, 2000.
Dr. Brennan’s previous experience includes six years in the biopharmaceutical industry, where he has served as Vice President, Business Development for Boehringer Mannheim Therapeutics.
Dr. Brennan received a B.S.
in Biochemistry, a Ph.D.
in neurobiology and a M.D.
from the University of Witwatersrand, Johannesburg, South Africa.
Michael J. Brennan active positions
| Companies | Position | Start |
|---|---|---|
Pearl Street Venture Funds
 Pearl Street Venture Funds Investment ManagersFinance Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana. | Private Equity Investor | - |
Cloud Pharmaceuticals, Inc.
 Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | Director/Board Member | - |
Former positions of Michael J. Brennan
| Companies | Position | End |
|---|---|---|
Ore Pharmaceuticals, Inc.
 Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Director/Board Member | 26/04/2009 |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Director/Board Member | 02/01/2008 |
Coastview Capital LLC
 Coastview Capital LLC Investment ManagersFinance Founded in 2001, Coastview Capital LLC is a venture capital firm headquartered in Los Angeles | Private Equity Investor | 29/06/2006 |
| TAURIGA SCIENCES, INC. | Director/Board Member | - |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Corporate Officer/Principal | - |
Training of Michael J. Brennan
| University of the Witwatersrand | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CASELLA WASTE SYSTEMS, INC. | Industrial Services |
| TAURIGA SCIENCES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
Coastview Capital LLC
Coastview Capital LLC Investment ManagersFinance Founded in 2001, Coastview Capital LLC is a venture capital firm headquartered in Los Angeles | Finance |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
Pearl Street Venture Funds
Pearl Street Venture Funds Investment ManagersFinance Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana. | Finance |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Health Technology |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Stock Market
- Insiders
- Michael J. Brennan